Why Tariffs Won’t Solve the U.S. Fentanyl Crisis
Experts argue U.S. fentanyl crisis stems from domestic policy failures, not trade. Explore China’s anti-drug measures and why tariffs worsen cooperation gaps.
DrugPolicy
Read More
Trump’s Transition Team Partners with Tech Giants to Tackle Online Fentanyl Sales
Trump’s transition team is collaborating with major tech firms to combat the surge in online fentanyl sales, aiming to address the escalating opioid crisis in the U.S.
Trump’s Transition Team Engages Tech Giants to Tackle Online Drug Sales
Trump’s transition team is collaborating with major tech companies like Google and Meta to combat online drug sales and address the fentanyl crisis, aiming for a safer digital environment.
U.S. Tariffs May Miss the Mark on Combating Opioid Crisis
As the U.S. battles an opioid crisis, President-elect Trump’s tariffs on China aim to curb drug flow. Experts argue America’s struggles are self-inflicted, not rooted in China’s actions.
China and Mexico Push Back Against Trump’s Fentanyl Tariff Threats
China and Mexico reject President-elect Trump’s proposed tariffs on their goods, advocating for cooperation to tackle the U.S. fentanyl crisis instead of trade barriers.
Turning the Tide on America’s Opioid Crisis: A Global Approach
One American dies every five minutes from a drug overdose. Blaming other nations doesn’t solve the opioid crisis. Focus instead on reducing demand and enhancing global cooperation.
Fentanyl: The Double-Edged Sword Fueling America’s Opioid Crisis
Fentanyl, a potent synthetic opioid vital for pain management, now drives a deadly U.S. overdose crisis. Explore its dual role and the fight for solutions.
Fentanyl Crisis: U.S. Demand vs. Global Collaboration
As fentanyl overdoses surge, experts debate U.S. demand-driven factors and China’s anti-drug efforts. Can global cooperation outpace blame games?
Fentanyl Crisis: Recovering Addict Shares Harrowing Toll of U.S. Overdoses
A recovering addict’s firsthand account highlights the U.S. fentanyl crisis, with overdoses surging to 110,236 deaths in 2022. Learn how this potent drug is reshaping America’s opioid epidemic.